SEQUENCIO Trademark
Trademark Overview
On Thursday, November 13, 2025, a trademark application was filed for SEQUENCIO with the United States Patent and Trademark Office. The USPTO has given the SEQUENCIO trademark a serial number of 99494302. The federal status of this trademark filing is WITHDRAWN BEFORE PUBLICATION as of Tuesday, April 28, 2026. This trademark is owned by Sequencio Therapeutics Company Limited. The SEQUENCIO trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for treatment of cancer; human vaccine preparations; anti-cancer preparations; anti-cancer agents; drugs for the treatment of cancer; drugs for medical purposes; medicines for human purposes; vaccines against cancer; anti-cancer drugs; therapeutic cancer vaccines; immunotherapeutic agent; biological preparations for the treatment of premalignant disease to prevent malignant transformation; biological preparations for the treatment of premalignant conditions
General Information
| Serial Number | 99494302 |
| Word Mark | SEQUENCIO |
| Filing Date | Thursday, November 13, 2025 |
| Status | 692 - WITHDRAWN BEFORE PUBLICATION |
| Status Date | Tuesday, April 28, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Vaccines; pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for treatment of cancer; human vaccine preparations; anti-cancer preparations; anti-cancer agents; drugs for the treatment of cancer; drugs for medical purposes; medicines for human purposes; vaccines against cancer; anti-cancer drugs; therapeutic cancer vaccines; immunotherapeutic agent; biological preparations for the treatment of premalignant disease to prevent malignant transformation; biological preparations for the treatment of premalignant conditions |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 13, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Sequencio Therapeutics Company Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Hong Kong 00000
HK |
Trademark Events
| Event Date | Event Description |
| Thursday, November 13, 2025 | NEW APPLICATION ENTERED |
| Thursday, November 13, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, November 13, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, March 23, 2026 | ASSIGNED TO EXAMINER |
| Monday, March 23, 2026 | NON-FINAL ACTION WRITTEN |
| Monday, March 23, 2026 | NON-FINAL ACTION E-MAILED |
| Monday, March 23, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, April 2, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 2, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 2, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 3, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, April 28, 2026 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
